(Q45358050)

13 December 2017

title

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation (English)

1 reference

13 December 2017

0 references

10

Marianne Wigger

1 reference

13 December 2017

Britta Höcker

1

1 reference

13 December 2017

Stephan Böhm

2

1 reference

13 December 2017

Helmut Fickenscher

3

1 reference

13 December 2017

Uta Küsters

4

1 reference

13 December 2017

Paul Schnitzler

5

1 reference

13 December 2017

Martin Pohl

6

1 reference

13 December 2017

Ulrike John

7

1 reference

13 December 2017

Markus J Kemper

8

1 reference

13 December 2017

Henry Fehrenbach

9

1 reference

13 December 2017

Martin Holder

11

1 reference

13 December 2017

Monika Schröder

12

1 reference

13 December 2017

Reinhard Feneberg

13

1 reference

13 December 2017

Sabine Köpf-Shakib

14

1 reference

13 December 2017

Burkhard Tönshoff

15

1 reference

13 December 2017

publication date

25 April 2012

1 reference

13 December 2017

published in

Transplant International

1 reference

13 December 2017

volume

25

1 reference

13 December 2017

issue

7

1 reference

13 December 2017

page(s)

723-731

1 reference

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

The role of EBV in post-transplant malignancies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Prophylactic oral ganciclovir after renal transplantation-dosing and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Pharmacokinetics of ganciclovir in pediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Detection of herpesvirus DNA in cerebrospinal fluid and correlation with clinical symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01485.X

10.1111/J.1432-2277.2012.01485.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference